Design and Simulation Study of Drug-Eluting Stents for Treating Hepatic Artery Stenosis Post Liver Transplantation

Authors

  • Shilpa Nagod
  • Sharanappa V. Halse

DOI:

https://doi.org/10.37591/(rrjobi).v7i1.852

Abstract

Hepatocellular carcinomais amongst the most common cancers worldwide, accounting for nearly 1 million deaths annually. Early diagnosis would help in treating with chemotherapy and ablative techniques but with most of the liver being affected; only transplantation would be a treatment of choice. Apparently, after orthotopic liver transplantation (OLT), an issue of hepatic artery stenosis (HAS) can occur which would later lead to hepatic artery thrombosis (HAT), with subsequent liver failure in 30% of patients. Operative intervention or retransplantation has been the traditional solution but endovascular therapy has emerged as a less invasive treatment strategy which would include placing of the stents. In the present paper we would discuss about designing a MEMS-based drug-eluting stent and its simulation study using Comsol Multiphysics to understand how HAS could be treated.

 

Keywords: hepatocellular carcinoma, hepatic artery thrombosis (HAT), hepatic artery stenosis (HAS), drug-eluting stent, simulation

 

Cite this Article

Shilpa Nagod, Sharanappa V. Halse. Design and Simulation Study of Drug-Eluting Stents for Treating Hepatic Artery Stenosis Post Liver Transplantation. Research & Reviews: A Journal of Bioinformatics. 2020; 7(1): 7–13p.

Downloads

Published

2020-05-11

Issue

Vol. 7 No. 1 (2020)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.